INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
DJ

Dowden Nathan J

President & COOCIK 0001873392

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score17
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
3
DJ
Dowden Nathan JPresident & COO
TRDAEntrada Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$26K
15.0K sh
May 4, 2026May 4, 2026
traded May 4, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Entrada Therapeutics, Inc.President & COO · May 4, 2026
17
DJ
Dowden Nathan JPresident & COO
TRDAEntrada Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL
$230K
15.0K sh
May 4, 2026
May 4, 2026
traded May 4, 2026
+0d
SEC FORM 4

Evidence

7
DJ
Dowden Nathan JPresident & COO
TRDAEntrada Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
15.0K sh
May 4, 2026May 4, 2026
traded May 4, 2026
+0dSEC FORM 4

Evidence